Patents by Inventor Brigitte Ternaux

Brigitte Ternaux has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD FOR OBTAINING CHARACTERIZED MUSCLE-DERIVED CELL POPULATIONS AND USES
    Publication number: 20110014159
    Abstract: A method for obtaining cell populations derived from the muscular tissue and their use for preparing cell therapy products includes culturing cells previously removed by biopsy from skeletal muscular tissues, identifying the different types of cells present at different stages of culture, selecting the culture stage on the basis of the required cell population and collecting the selected culture stage for preparing a cell therapy product. The invention also concerns cell populations derived from muscular tissue obtained by implementing the method whereof the dominant cell type is CD34+, CD15+ or CD56+ or Class 1+HLA, or comprises a doubly negative CD56?/CD15? cell type or may comprise more minority CD10+, Stro-1+ and CD 117+ cell types.
    Type: Application
    Filed: June 2, 2010
    Publication date: January 20, 2011
    Applicants: ASSISTANCE PUBLIQUE - HOSPITAUX DE PARIS, INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE, ASSOCIATION FRANCAISE CONTRE LES MYOPATHIES
    Inventors: Jean-Thomas Vilquin, Jean-Pierre Marolleau, Jacques Tremblay, Isabelle Robert, Brigitte Ternaux
  • Method for obtaining characterized muscle-derived cell populations and uses
    Publication number: 20060088508
    Abstract: A method for obtaining cell populations derived from the muscular tissue and their use for preparing cell therapy products includes culturing cells previously removed by biopsy from skeletal muscular tissues, identifying the different types of cells present at different stages of culture, selecting the culture stage on the basis of the required cell population and collecting the selected culture stage for preparing a cell therapy product. The invention also concerns cell populations derived from muscular tissue obtained by implementing the method whereof the dominant cell type is CD34+, CD15+ or CD56+ or Class 1+ HLA, or comprises a doubly negative CD56?/CD15? cell type or may comprise more minority CD10+, Stro-1+ and CD117+ cell types.
    Type: Application
    Filed: August 22, 2005
    Publication date: April 27, 2006
    Applicants: ASSISTANCE PUBLIQUE - HOSPITAUX DE PARIS, INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE, ASSOCIATION FRANCAISE CONTRE LES MYOPATHIES
    Inventors: Jean-Thomas Vilquin, Jean-Pierre Marolleau, Jacques Tremblay, Isabelle Robert, Brigitte Ternaux
  • Method for obtaining characterised muscle-derived cell populations and uses
    Publication number: 20040043008
    Abstract: A method for obtaining cell populations derived from the muscular tissue and their use for preparing cell therapy products includes culturing cells previously removed by biopsy from skeletal muscular tissues, identifying the different types of cells present at different stages of culture, selecting the culture stage on the basis of the required cell population and collecting the selected culture stage for preparing a cell therapy product. The invention also concerns cell populations derived from muscular tissue obtained by implementing the method whereof the dominant cell type is CD34+, CD15+ or CD56+ or Class 1+ HLA, or comprises a doubly negative CD56−/CD15− cell type or may comprise more minority CD10+, Stro-1+ and CD117+ cell types.
    Type: Application
    Filed: December 9, 2002
    Publication date: March 4, 2004
    Inventors: Jean-Thomas Vilquin, Jean-Pierre Marolleau, Jacques Tremblay, Isabelle Robert, Brigitte Ternaux